Clinical trial NCT01506115 - References

Hepatocellular Carcinoma — Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma

Citation(s)

•   A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
  Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. N Engl J Med. 1995 May 11;332(19):1256-61.
•   Chen MF, Jan YY, Jeng LB, Hwang TL, Wang CS, Chen SC
  Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 cases. Cancer. 1994 Mar 1;73(5):1335-40.
•   Cho HC, Lee JK, Lee KH, Lee KT, Paik S, Choo SW, Do YS, Choo IW
  Are endoscopic or percutaneous biliary drainage effective for obstructive jaundice caused by hepatocellular carcinoma? Eur J Gastroenterol Hepatol. 2011 Mar;23(3):224-31. doi: 10.1097/MEG.0b013e3283436ff6.
•   Dumoulin FL, Gerhardt T, Fuchs S, Scheurlen C, Neubrand M, Layer G, Sauerbruch T
  Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2003 Jun;57(7):860-7.
•   El-Serag HB
  Hepatocellular carcinoma. N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683. Review.
•   Harewood GC, Baron TH, Rumalla A, Wang KK, Gores GJ, Stadheim LM, de Groen PC
  Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol. 2005 Mar;20(3):415-20.
•   Hu J, Pi Z, Yu MY, Li Y, Xiong S
  Obstructive jaundice caused by tumor emboli from hepatocellular carcinoma. Am Surg. 1999 May;65(5):406-10.
•   Ikenaga N, Chijiiwa K, Otani K, Ohuchida J, Uchiyama S, Kondo K
  Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg. 2009 Mar;13(3):492-7. doi: 10.1007/s11605-008-0751-0. Epub 2008 Nov 15.
•   Kahaleh M, Mishra R, Shami VM, Northup PG, Berg CL, Bashlor P, Jones P, Ellen K, Weiss GR, Brenin CM, Kurth BE, Rich TA, Adams RB, Yeaton P
  Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol. 2008 Mar;6(3):290-7. doi: 10.1016/j.cgh.2007.12.004. Epub 2008 Feb 6.
•   Kubota Y, Seki T, Kunieda K, Nakahashi Y, Tani K, Nakatani S, Yamaguchi T, Mizuno T, Inoue K
  Biliary endoprosthesis in bile duct obstruction secondary to hepatocellular carcinoma. Abdom Imaging. 1993;18(1):70-5.
•   Lai EC, Lau WY
  Hepatocellular carcinoma presenting with obstructive jaundice. ANZ J Surg. 2006 Jul;76(7):631-6. Review.
•   Lau W, Leung K, Leung TW, Liew CT, Chan MS, Yu SC, Li AK
  A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surg. 1997 Mar;225(3):281-5.
•   Lau WY, Leow CK, Leung KL, Leung TW, Chan M, Yu SC
  Cholangiographic features in the diagnosis and management of obstructive icteric type hepatocellular carcinoma. HPB Surg. 2000;11(5):299-306.
•   Lau WY, Leung JW, Li AK
  Management of hepatocellular carcinoma presenting as obstructive jaundice. Am J Surg. 1990 Sep;160(3):280-2.
•   Matsueda K, Yamamoto H, Umeoka F, Ueki T, Matsumura T, Tezen T, Doi I
  Effectiveness of endoscopic biliary drainage for unresectable hepatocellular carcinoma associated with obstructive jaundice. J Gastroenterol. 2001 Mar;36(3):173-80.
•   Ortner MA
  Photodynamic therapy for cholangiocarcinoma: overview and new developments. Curr Opin Gastroenterol. 2009 Sep;25(5):472-6. doi: 10.1097/MOG.0b013e32832e6e1f. Review.
•   Ortner ME, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mössner J, Lochs H
  Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003 Nov;125(5):1355-63.
•   Qin LX, Tang ZY
  Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol. 2003 Mar;9(3):385-91. Review.
•   Rumalla A, Baron TH, Wang KK, Gores GJ, Stadheim LM, de Groen PC
  Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc. 2001 Apr;53(4):500-4.
•   Shim CS, Cheon YK, Cha SW, Bhandari S, Moon JH, Cho YD, Kim YS, Lee LS, Lee MS, Kim BS
  Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy. 2005 May;37(5):425-33.
•   Singal AG, Marrero JA
  Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol. 2010 May;26(3):189-95. doi: 10.1097/MOG.0b013e3283383ca5. Review.
•   Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M
  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006 Aug;244(2):230-9.
•   Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF
  Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol. 2005 Nov;100(11):2426-30.

Observational Study for Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma

Details for clinical trial NCT01506115